N-(3-methylphenyl)-3-(4-nitro-1,3-dioxoisoindol-2-yl)propanamide
C18H15N3O5 — CID 1115307
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-(3-methylphenyl)-3-(4-nitro-1,3-dioxoisoindol-2-yl)propanamide
N-(3-methylphenyl)-3-(4-nitro-1,3-dioxoisoindol-2-yl)propanamide (PubChem CID 1115307) has the molecular formula C18H15N3O5 and a molecular weight of 353.33 g/mol. Its IUPAC name is N-(3-methylphenyl)-3-(4-nitro-1,3-dioxoisoindol-2-yl)propanamide.
Molecular Properties
| Compound Name | N-(3-methylphenyl)-3-(4-nitro-1,3-dioxoisoindol-2-yl)propanamide |
|---|---|
| PubChem CID | 1115307 |
| Molecular Formula | C18H15N3O5 |
| Molecular Weight | 353.33 g/mol |
| Exact Mass | 353.10 |
| IUPAC Name | N-(3-methylphenyl)-3-(4-nitro-1,3-dioxoisoindol-2-yl)propanamide |
| SMILES | Cc1cccc(NC(=O)CCN2C(=O)c3cccc([N+](=O)[O-])c3C2=O)c1 |
| InChI | InChI=1S/C18H15N3O5/c1-11-4-2-5-12(10-11)19-15(22)8-9-20-17(23)13-6-3-7-14(21(25)26)16(13)18(20)24/h2-7,10H,8-9H2,1H3,(H,19,22) |
| InChIKey | XBNUCSFWFSWJLX-UHFFFAOYSA-N |
| XLogP | 2.53 |
| TPSA | 109.62 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 26 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 353.33 |
| LogP ≤ 5 | 2.53 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'nitro_group', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 1115307 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.